Article Versions Notes

Seales CL, Puri D, Yodkhunnatham N, Pandit K, Yuen K, Murray S, Smitham J, Lafin JT, Bagrodia A. Advancing GCT Management: A Review of miR-371a-3p and Other miRNAs in Comparison to Traditional Serum Tumor Markers. Cancers. 2024; 16(7):1379. https://doi.org/10.3390/cancers16071379

Seales, Crystal L., Dhruv Puri, Nuphat Yodkhunnatham, Kshitij Pandit, Kit Yuen, Sarah Murray, Jane Smitham, John T. Lafin, and Aditya Bagrodia. 2024. "Advancing GCT Management: A Review of miR-371a-3p and Other miRNAs in Comparison to Traditional Serum Tumor Markers" Cancers 16, no. 7: 1379. https://doi.org/10.3390/cancers16071379

Seales, C. L., Puri, D., Yodkhunnatham, N., Pandit, K., Yuen, K., Murray, S., Smitham, J., Lafin, J. T., & Bagrodia, A. (2024). Advancing GCT Management: A Review of miR-371a-3p and Other miRNAs in Comparison to Traditional Serum Tumor Markers. Cancers, 16(7), 1379. https://doi.org/10.3390/cancers16071379